Payer Coverage of Biosimilars Always Shifting, Says Dr Tasmina Hydery

Payer coverage of biosimilars is always shifting as new ones come to market, explained Tasmina Hydery, PharmD, MBA, BCGP, associate director in digital solutions, Cencora.

Related Keywords

United States ,Nevada ,Las Vegas ,Gillian Woollett ,Samsung Bioepis ,Tasmina Hydery ,Joseph Park ,Oncology Practice Network ,Biosimilars Collective Intelligence Consortium ,Health Systems ,Pharmacy Practice ,Asembia Specialty Pharmacy Summit ,Lakesha Farmer ,Practice Network ,Cate Lockhart ,Biosimilars Collective Intelligence ,Biosimilars ,Payer Coverage ,